Loading...
ALSMA logo

S.M.A.I.O S.A.ENXTPA:ALSMA Stock Report

Market Cap €43.9m
Share Price
€7.80
€8.4
7.1% undervalued intrinsic discount
1Y105.3%
7D7.1%
Portfolio Value
View

S.M.A.I.O S.A.

ENXTPA:ALSMA Stock Report

Market Cap: €43.9m

S.M.A.I.O (ALSMA) Stock Overview

Provides software, implantable devices, and associated services to treat spinal pathologies requiring surgery. More details

ALSMA fundamental analysis
Snowflake Score
Valuation0/6
Future Growth5/6
Past Performance0/6
Financial Health4/6
Dividends0/6

ALSMA Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

S.M.A.I.O S.A. Competitors

Price History & Performance

Summary of share price highs, lows and changes for S.M.A.I.O
Historical stock prices
Current Share Price€7.80
52 Week High€8.70
52 Week Low€3.46
Beta0.53
1 Month Change9.86%
3 Month Change6.85%
1 Year Change105.26%
3 Year Change128.07%
5 Year Changen/a
Change since IPO40.04%

Recent News & Updates

Recent updates

Returns On Capital Are Showing Encouraging Signs At S.M.A.I.O (EPA:ALSMA)

Jul 20
Returns On Capital Are Showing Encouraging Signs At S.M.A.I.O (EPA:ALSMA)

Shareholder Returns

ALSMAFR Medical EquipmentFR Market
7D7.1%8.6%2.1%
1Y105.3%-13.5%10.4%

Return vs Industry: ALSMA exceeded the French Medical Equipment industry which returned -13.5% over the past year.

Return vs Market: ALSMA exceeded the French Market which returned 10.4% over the past year.

Price Volatility

Is ALSMA's price volatile compared to industry and market?
ALSMA volatility
ALSMA Average Weekly Movement5.1%
Medical Equipment Industry Average Movement5.1%
Market Average Movement5.3%
10% most volatile stocks in FR Market10.6%
10% least volatile stocks in FR Market3.0%

Stable Share Price: ALSMA has not had significant price volatility in the past 3 months compared to the French market.

Volatility Over Time: ALSMA's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
200941Philippe Roussoulysmaio.com

S.M.A.I.O S.A. provides software, implantable devices, and associated services to treat spinal pathologies requiring surgery. It offers solutions for surgeons including programs for training, assistance with surgical planning based on a database called KEOPS. The company also offers solutions such as i-PLAN, take control of the realignment plan; i-PERFORM, take control of the surgical plan; i-CHECK, take control of the outcome data; and i-LEARN, take control of the education.

S.M.A.I.O S.A. Fundamentals Summary

How do S.M.A.I.O's earnings and revenue compare to its market cap?
ALSMA fundamental statistics
Market cap€43.93m
Earnings (TTM)-€1.85m
Revenue (TTM)€8.28m
5.3x
P/S Ratio
-23.7x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ALSMA income statement (TTM)
Revenue€8.28m
Cost of Revenue€1.34m
Gross Profit€6.94m
Other Expenses€8.80m
Earnings-€1.85m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

Oct 13, 2026

Earnings per share (EPS)-0.33
Gross Margin83.83%
Net Profit Margin-22.35%
Debt/Equity Ratio41.8%

How did ALSMA perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/20 10:39
End of Day Share Price 2026/04/17 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

S.M.A.I.O S.A. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Florian CariouTPICAP Midcap